CalciMedica Quote - CALC

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.70

Bid

2.66

Offer

2.95

Volume

0.00 Day's Range 0.00

2.05 52 Week Range 8.38

Market Cap

36.401M

Previous Close

2.70

Open

Last Trade

2.66

Last Trade Time

00:00:07

Financial Volume

VWAP

Average Volume (3m)

61,495

Shares Outstanding

13,481,917

Dividend Yield

PE Ratio

-1.06

Earnings Per Share (EPS)

-2.55

Revenue

Net Profit

-34.36M

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.calcimedica.com

Headquarters

Wilmington, Delaware, USA

Founded

CalciMedica Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALC. The last closing price for CalciMedica was US$2.70. Over the last year, CalciMedica shares have traded in a share price range of US$ 2.05 to US$ 8.38.

CalciMedica currently has 13,481,917 shares in issue. The market capitalisation of CalciMedica is US$36.40 million. CalciMedica has a price to earnings ratio (PE ratio) of -1.06.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.38	-12.3376623377	3.08	3.295	2.05	188168	2.84236551	CS
4	-0.65	-19.4029850746	3.35	3.55	2.05	72674	3.01257203	CS
12	-1.24	-31.4720812183	3.94	5.65	2.05	61495	3.55540016	CS
26	-2.45	-47.572815534	5.15	5.97	2.05	54917	3.87394372	CS
52	-0.53	-16.4086687307	3.23	8.38	2.05	36878	4.12948342	CS
156	-13.68	-83.5164835165	16.38	16.38	1.17	15781	4.01675819	CS
260	-13.68	-83.5164835165	16.38	16.38	1.17	11319	4.01675819	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PALIPalisade Bio Inc	US$ 3.20 (128.57%)	20.1M
SYTASiyata Mobile Inc	US$ 1.05 (40.37%)	12.24M
TRVITrevi Therapeutics Inc	US$ 3.40 (36.55%)	2.47M
ZENAZenaTech Inc	US$ 7.46 (31.11%)	3.6M
ATLNAtlantic International Corporation	US$ 7.00 (22.74%)	1
KROSKeros Therapeutics Inc	US$ 18.78 (-72.64%)	609.66k
SPGCSacks Parente Golf Inc	US$ 0.50 (-64.29%)	163.73k
PNBKPatriot National Bancorp Inc	US$ 1.08 (-58.78%)	16
AVGRAvinger Inc	US$ 0.441 (-46.22%)	87.3k
HEPAHepion Pharmaceuticals Inc	US$ 0.36 (-38.46%)	1
PALIPalisade Bio Inc	US$ 3.20 (128.57%)	20.1M
CDTConduit Pharmaceuticals Inc	US$ 0.1012 (14.61%)	14.2M
AMPGAmplitech Group Inc	US$ 2.20 (13.99%)	13.48M
SYTASiyata Mobile Inc	US$ 1.05 (40.37%)	12.24M
LAESSEALSQ Corporation	US$ 1.245 (8.26%)	8.74M